MentionFox
Home › Executive changes › Week of 2026-09-28
Leadership changes · weekly

Executive changes, week of 2026-09-28

Every leadership change public companies reported to the SEC under Item 5.02 the week of 2026-09-28: who left, who was appointed, and to what role, each linked to the filing.

Companies29
Named changes25
CEO changes2
CFO changes4

29 public companies reported a change among their directors or officers the week of 2026-09-28. 25 changes name the person, including 2 at chief executive and 4 at chief financial officer.

CompanyChangePersonRoleEffectiveFiling
Neurocrine Biosciences IncAppointedEiry W. RobertsChief Medical Officer2026-09-288-K
Vestis CorpAppointedRussell TiejemaChief Financial Officer8-K
Gain Therapeutics, Inc.AppointedGene MackChief Financial Officer2026-10-018-K
Adeia Inc.DepartingPaul E. DavisDirector8-K
Adeia Inc.AppointedDipti Vachani2026-10-128-K
Hain Celestial Group IncDepartingMichael J. RagusaChief Accounting Officer2026-11-018-K
Hain Celestial Group IncAppointedLee A. BoyceChief Financial Officer8-K
Matternet, Inc.AppointedAndreas RaptopoulosChief Executive Officer2026-09-298-K
Tempest Therapeutics, Inc.AppointedConstance AmesChief Financial Officer8-K
Emmis Acquisition Corp.AppointedKenneth C. GreenbergDirector8-K
Jasper Therapeutics, Inc.AppointedJeet MahalPrincipal Financial Officer8-K
Fuller H B CoDepartingRuth S. KimmelshueDirector8-K
Fuller H B CoAppointedR. Jeffrey BaillyDirector2026-09-238-K
World Gold TrustAppointedJoan A. Binstock2026-09-288-K
Spdr Gold TrustAppointedJoan A. Binstock2026-09-288-K
Par Pacific Holdings, Inc.AppointedRichard Creamer8-K
Biotricity Inc.DepartingJainal BhuiyanDirector2026-09-228-K
Celularity IncAppointedPhilip A. BarachDirector2026-09-248-K
Celularity IncAppointedPhilip A. Barach8-K
MongoDB, Inc.AppointedDev IttycheriaPresident and Chief Executive Officer2026-09-288-K
Asana, Inc.AppointedDan RogersChair of the Board8-K
Asana, Inc.AppointedTom BerquistDirector8-K
Asana, Inc.AppointedJerry TingDirector8-K
Asana, Inc.AppointedHeather LeChief Accounting Officer and Principal Accounting Officer8-K
Humacyte, Inc.AppointedScott Coward8-K

Also filed that week

Download this data (CSV)25 rows, with sources

Tools for this story

Each opens in a new tab. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/week/2026-40
Last updated 2026-09-29
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Executive changes filed the week of 2026-09-28: 29 companies, 2 CEO, 4 CFO. MentionFox, 2026-09-29. https://mentionfox.com/executive-changes/week/2026-40